Company: ISRG
Filing Date: 2025-10-22
Form Type: 10-Q
Source: 0001035267-25-000209
Chunk: 27

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-10-22
Form: 10-Q
Item: Item 1
Chunk 27
---
loss)(2.9)0.3 — 0.4 (2.2)Net current-period other comprehensive income (loss)(13.2)41.7 48.9 0.4 77.8 Ending balance$(2.2)$27.1 $15.8 $(14.2)$26.5 

19

Nine Months Ended September 30, 2024Losses on Hedge InstrumentsUnrealized Gains (Losses) on Available-for-Sale SecuritiesForeign Currency Translation Gains (Losses)Employee Benefit PlansTotalBeginning balance$(2.5)$(29.7)$19.4 $0.6 $(12.2)Other comprehensive income (loss) before reclassifications(10.5)60.6 (30.3)— 19.8 Amounts reclassified from accumulated other comprehensive income (loss)5.4 0.2 — (0.3)5.3 Net current-period other comprehensive income (loss)(5.1)60.8 (30.3)(0.3)25.1 Ending balance$(7.6)$31.1 $(10.9)$0.3 $12.9 

The tax impacts for amounts recognized in other comprehensive income before reclassifications and reclassified from accumulated other comprehensive income (loss) relating to hedge instruments, available-for-sale securities, foreign currency translation gains (losses), and employee benefit plans for the three and nine months ended September 30, 2025, and 2024, were not material to the Company’s Financial Statements.

NOTE 10.    SHARE-BASED COMPENSATION

In May 2025, the Company’s shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from 115,350,000 to 120,350,000. As of September 30, 2025, approximately 22.1 million shares were reserved for future issuance under the Company’s stock plans, and a maximum of approximately 9.6 million of these shares can be awarded as restricted stock units (“RSUs”).Restricted Stock UnitsRSU activity under all stock plans for the nine months ended September 30, 2025, was as follows (in millions, except per share amounts): SharesWeighted-AverageGrant